| |
|
|
|
Harvard Bioscience Inc.  
|
|
7.77 0.17 (0.02%) |
09-21 11:21 |
|
Open: |
7.57 |
Pre close: |
7.6 |
Target:
|
9.43
|
|
High: |
7.79 |
Low: |
7.57 |
Resistance:
|
8.08
8.48
|
|
Volume: |
51,038 |
Market Cap: |
310M |
Support:
|
7.43
6.18
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.75
 |
MACD |
MACD(12,26):
|
-0.10 |
|
MA(20): |
8.03  |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
7.70 |
Stochastic Oscillator |
%K(14,3):
|
24.40 |
|
MA(250): |
5.81 |
%D(3): |
28.62 |
|
Average Volume(K) |
3-Month: |
748811
|
52-Week |
High:
|
8.75 |
|
10-Days: |
19336 |
Low: |
2.74 |
|
RSI |
RSI(14):
|
44.72 |
Change(%): |
173.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.200 |
Return on Equity (ttm) |
-5.2 |
Shares Out. (M) |
39.93 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
1.2 |
Shares Float (M) |
35.78 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.98 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
13.5 |
% Held by Institutions |
73.84 |
|
Forward EPS |
-0.080 |
Gross Profit (p.s.) |
1.454 |
Shares Short (K) |
798 |
|
Book Value (p.s.) |
1.950 |
EBITDA (p.s.) |
0.264 |
P/E |
-38.95 |
|
Sales Per Share |
2.638 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.99 |
|
Profit Margin |
-3.76 |
Operating Cash Flow
(M) |
7.50 |
P/S |
2.95 |
|
Operating Margin |
2.76 |
Levered Free Cash Flow
(M) |
7.94 |
P/CF |
41.47 |
|
|
|
|
|
|
